KOLOA, Hawaii — Ninety-two percent of patients do not take drops adequately after cataract surgery, John A. Hovanesian, MD, said at Hawaiian Eye 2020.
According to Hovanesian, there are a few options to solve this problem: use fewer drops or eliminate them all together.
“We need a solution that will be FDA approved, ideally one that is proven safe and effective, delivered close to the target tissue, inexpensive or reimbursed to our patients, and kind to the surface of the eye,” he said.
Lotemax SM (loteprednol etabonate ophthalmic gel 0.38%, (Read more...)
Uncategorized